Search

Search Constraints

You searched for: Author/Creator Mouy, Richard

Search Results

1. A169: Cumulative Long‐Term Safety, Efficacy and Patient‐Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment. Issue 11 (March 2014)

2. A169: Cumulative Long‐Term Safety, Efficacy and Patient‐Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

3. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Issue 6 (21st May 2013)

4. Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate. Issue 2 (13th July 2020)

5. Long‐Term Safety, Efficacy, and Quality of Life in Patients With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept for Up to Seven Years. Issue 10 (23rd September 2015)

6. SAT0486 SERIOUS ADVERSE EVENTS OF TOCILIZUMAB IN CHILDREN WITH RHEUMATIC DISEASES – A REAL-WORLD EXPERIENCE. (June 2019)

7. The identification of MAFB mutations in eight patients with multicentric carpo–tarsal osteolysis supports genetic homogeneity but clinical variability. Issue 12 (16th August 2013)

8. The identification of MAFB mutations in eight patients with multicentric carpo–tarsal osteolysis supports genetic homogeneity but clinical variability. Issue 12 (16th August 2013)